Biosimilars
Dr. Reddy’s Laboratories Launches Versavo (biosimilar, bevacizumab) for Multiple Cancer
Shots: Dr. Reddy’s has launched Versavo (bevacizumab), a biosimilar of Roche’s Avastin in 100mg and 400mg single use vials for the treatment of multiple cancers including m-colorectal cancer, NSCLC, recurrent […]readmore